SDGR — Schrödinger, Inc. stock price, charts and financials

NASDAQ·Technology·Software - Application·USA

Latest market price

18.61

+0.45+2.48%

Overview Short InterestFilings

SDGRQT67Schrödinger, Inc.·NASDAQ

Overview Short InterestFilings

18.61+2.48%

Loading chart...

Signal & projected range

Earnings big beat — drift (PEAD)Historical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

LSPD+1.63%$10.63 WLTH-0.77%$9.63 GTM+1.44%$4.24 AMPL+6.66%$12.01 BRAI-1.59%$5.58 DFIN-0.27%$47.25 UPBD-2.70%$19.29 CXM+1.68%$6.97

Snapshot

Index	-	P/E	-	EPS (ttm)	-1.41	Insider Own	13.89%	Shs Outstand	74.72M	Perf Week	19.95%

Market Cap	1.36B	Forward P/E	-	EPS next Y	-1.47	Insider Trans	-0.99%	Shs Float	57.65M	Perf Month	8.16%

Enterprise Value	1.18B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	18.36%	Perf Quarter	36.75%

Income	-54.28M	P/S	5.24	EPS this Y	-16.44%	Inst Trans	-	Short Ratio	7.27	Perf Half Y	40.34%

Sales	259.04M	P/B	4.12	EPS next Y	10.63%	ROA	-8.48%	Short Interest	10.58M	Perf YTD	1.57%

Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-16.37%	52W High	23.59 -21.11%	Perf Year	-6.10%

Cash/sh	-	P/FCF	-	EPS past 3/5Y	-	ROIC	-31.77%	52W Low	11.22 65.84%	Perf 3Y	-63.85%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.25% 18.84%	Gross Margin	56.87%	Volatility	5.94% 4.56%	Perf 5Y	-73.16%

Dividend TTM	-	EV/Sales	4.54	EPS Y/Y TTM	45.14%	Oper. Margin	-59.24%	ATR (14)	0.87	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	2.71	Sales Y/Y TTM	22.60%	Profit Margin	-20.98%	RSI (14)	72.99	Recom	2.33

Dividend Gr. 3/5Y	-	Current Ratio	2.71	EPS Q/Q	1.22%	SMA20	15.51%	Beta	1.65	Target Price	24.80

Payout	0.00%	Debt/Eq	0.33	Sales Q/Q	-1.67%	SMA50	16.26%	Rel Volume	1.06	Prev Close	18.16

Employees	850	LT Debt/Eq	0.26	Earnings	Nov 04	SMA200	19.86%	Avg Volume	1.29M	Price	18.61

IPO Date	Feb 05, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-29.93% 23.15%	Net Debt/EBITDA	3.92	Volume	1,370,723	Change	2.48%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jan-07-26	Reiterated	UBS		$18
Dec-15-25	Upgrade	B of A Securities	Neutral → Buy
Sep-29-25	Initiated	Goldman Sachs	Neutral	$27 → $19
Aug-15-25	Downgrade	Citigroup	Buy → Neutral
Nov-13-24	Reiterated	BMO Capital	Outperform	$28
Sep-23-24	Reiterated	Goldman Sachs	Neutral	$23 → $27
Aug-21-24	Reiterated	Morgan Stanley	Equal Weight	$30
Jul-02-24	Initiated	Leerink	Outperform	$29
Dec-19-22	Initiated	Goldman Sachs	Neutral	$23
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal Weight

Latest News

Aug-06-26

Aug-06-2605:01AM

Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcriptseekingalpha.com

01:04AM

Schrodinger Q2 Earnings Call Highlightsmarketbeat.com

Aug-05-26

Aug-05-2609:36PM

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimateszacks.com

04:05PM

Schrödinger Reports Second Quarter 2026 Financial Resultsbusinesswire.com

08:30AM

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discoverybusinesswire.com

Aug-03-26

Aug-03-2610:11PM

Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For ItSeekingAlpha

Jul-27-26

Jul-27-2607:35AM

Schrödinger Rolls Out Early Access Version Of BunsenBenzinga

07:30AM

Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discoverybusinesswire.com

Jul-23-26

Jul-23-2609:05AM

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbersprnewswire.com

Jul-22-26

Jul-22-2608:30AM

Schrödinger to Announce Second Quarter 2026 Financial Results on August 5businesswire.com

Jul-21-26

Jul-21-2603:16AM

Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc.defenseworld.net

Jul-20-26

Jul-20-2608:30AM

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)businesswire.com

Jul-08-26

Jul-08-2603:34PM

Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery FieldSeekingAlpha

Jul-01-26

Jul-01-2612:16PM

AMD Is Up 150% This Year But Here Are 5 Overlooked Stocks Betting on What Comes Next247wallst.com

Jun-30-26

Jun-30-2609:36PM

A Look at Schrodinger Inc (SDGR) After 6.6% Decline -- GF Value $26.32 vs Price $16.25gurufocus.com

Company

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	259	256	208	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	111	113	75	—	—	—	—	—	—
Gross Profit	147	143	132	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	132	136	140	—	—	—	—	—	—
Research and Development	169	173	202	—	—	—	—	—	—
Other Operating Expense	-1	1	-1	—	—	—	—	—	—
Operating Income	-154	-167	-209	—	—	—	—	—	—
Interest Expense	0	0	0	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	101	65	24	—	—	—	—	—	—
Net Income Before Taxes	-53	-102	-186	—	—	—	—	—	—
Income Taxes	1	1	1	—	—	—	—	—	—
Consolidated Net Income	-54	-103	-187	—	—	—	—	—	—
Net Income From Continuing Operations	-54	-103	-187	—	—	—	—	—	—
Net Income	-54	-103	-187	—	—	—	—	—	—
EPS (Recurring)	-0.74	-1.41	-2.57	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.74	-1.41	-2.57	—	—	—	—	—	—
EPS (Diluted)	-0.74	-1.41	-2.57	—	—	—	—	—	—
EBITDA	-46	-96	-180	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	5.39	5.10	6.77	—	—	—	—	—	—
Gross Margin	56.76	55.86	63.46	—	—	—	—	—	—
Operating Margin	-59.46	-65.23	-100.48	—	—	—	—	—	—
Net Margin	-20.85	-40.23	-89.90	—	—	—	—	—	—
Shares Outstanding	75	73	73	—	—	—	—	—	—
Market Capitalization	1,396	1,305	1,408	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jain Rachit	EVP & CFO	Jul 16 '26	Sale	15.60	875	13,647	50,877	Jul 17
Farid Ramy	President & CEO	Apr 17 '26	Sale	12.21	43,000	524,944	330,824	Apr 17
Farid Ramy	President & CEO	Apr 17 '26	Option Exercise	3.07	117,527	360,808	405,351	Apr 17
Farid Ramy	President & CEO	Apr 16 '26	Option Exercise	3.07	43,000	132,010	117,527	Apr 17
Farid Ramy	President & CEO	Apr 16 '26	Sale	12.33	43,000	530,233	330,824	Apr 17
Jain Rachit	EVP & CFO	Apr 16 '26	Sale	12.75	844	10,758	51,752	Apr 17
Herman Jenny	CAO	Mar 06 '26	Sale	12.84	608	7,808	34,804	Mar 06
Tran Yvonne	EVP, CLO & CPO	Mar 05 '26	Sale	12.89	1,094	14,107	52,683	Mar 06
Herman Jenny	CAO	Mar 05 '26	Sale	12.85	775	9,956	35,412	Mar 06
Jain Rachit	EVP & CFO	Mar 05 '26	Sale	12.90	1,631	21,033	52,596	Mar 06
Farid Ramy	President & CEO	Mar 05 '26	Sale	12.91	3,661	47,249	330,824	Mar 06
Akinsanya Karen	See Remarks	Mar 05 '26	Sale	12.90	1,366	17,625	69,956	Mar 06
Lorton Kenneth Patrick	EVP, CTO & COO, Software	Mar 05 '26	Sale	12.90	1,222	15,761	89,241	Mar 06
Abel Robert Lorne	See Remarks	Mar 04 '26	Sale	12.81	1,300	16,653	55,897	Mar 06
Tran Yvonne	EVP, CLO & CPO	Feb 10 '26	Sale	13.80	776	10,705	22,859	Feb 12

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.